FDA Approved: VINCRISTINE SULFATE — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

The FDA approved a supplemental application filed by Hospira for vincristine sulfate, a generic vincristine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Ewing Sarcoma
• Hodgkin Lymphoma
• Lymphoblastic Lymphoma
• Neuroblastoma
• Non-hodgkin Lymphoma
• Rhabdomyosarcoma
• Wilms Tumor

Drugs mentioned

• Vincristine sulfate (VINCRISTINE SULFATE)

Snippet

SUPPL AP for VINCRISTINE SULFATE (VINCRISTINE SULFATE)